|Articles|November 13, 2018

HBA Annual Conference Convenes in Washington D.C.

HBA’s Annual Conference was held in Washington, D.C. on November 5-6, with over 900 attendees-both men and women.

HBA’s ACE Awards kicked-off the conference activities with a luncheon event that honored the 2018 recipients-Pfizer, Insigniam, and KMPG for their women’s leadership initiatives. An ACE Awards retrospective also recognized the previous 12 recipients in appreciation for integrating women’s leadership programs into their organizational DNA.

 

Topics at the conference ranged from “How Artificial Intelligence and Machine Learning are Transforming Healthcare” to “Find Your Mojo and Leverage Your Superpowers.” Lisa Henderson, Pharm Exec’s editorial director, spoke about Pharm Exec’s coverage and support of female industry leaders. Attendees also heard from mindfulness expert Susan O’Connor, a former executive at Pfizer, who shared her approach on how to balance personal well-being with the demands of work life. Lisa Bodell, founder, future think, closed out the conference sharing best practices on how to eliminate complexity from the daily grind. 

 


Related to this article

Pharmaceutical Executive Daily
The FDA approves Roche’s Tecentriq for a subset of colon cancer patients, TRexBio and Retension Pharmaceuticals price new IPOs, and a Pharmaceutical Executive feature examines what it takes to turn precision medicine’s biological gains into deliverable therapies.
Naoki Okamura: Post-Patent Plan and Purpose
Astellas CEO Naoki Okamura is putting a “patient axis” operating model, a broader portfolio of strategic brands and a new generation of science to work in the company’s bid to return to record growth.